Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > Trains Leaving The Station!!!
View:
Post by shareswapper on Dec 01, 2020 12:35pm

Trains Leaving The Station!!!

All aboard! Choo, Choo!!!!
Comment by ACEJackSuited on Dec 02, 2020 10:54am
This post has been removed in accordance with Community Policy
Comment by LFC1973 on Dec 02, 2020 2:07pm
Will be able to get them at the equivalent of 0.005 after the reverse split.  It will consolidate at 0.01 and be worth 0.20, and then drop down to 0.10 within a week.  
Comment by Iotamaniac1969 on Dec 03, 2020 5:04pm
This post has been removed in accordance with Community Policy
Comment by Iotamaniac1969 on Dec 03, 2020 5:04pm
This post has been removed in accordance with Community Policy
Comment by LFC1973 on Dec 04, 2020 2:53pm
Do you see any tangible information or updates coming out before the end of the year?  Even with the news regarding the trial data the stock hasn't moved.  I'm just saying that with no other updates before the end of the year, this will consolidate 20/1 at 0.01.  Start trading at .20 and then drop to .10.  I have faith in the long term for this company but don't see ...more  
Hemostemix Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities